Marijuana is often effective in treating the symptoms of both Parkinson’s disease and multiple sclerosis, and can help those with these conditions reduce their use of prescription drugs.
This is according to a new study published by the journal Complementary Therapies in Medicine, and published online by the U.S. National Institute of Health.
“Cannabis has been used for medicinal purpose for thousands of years; however the positive and negative effects of cannabis use in Parkinson’s disease (PD) and Multiple Sclerosis (MS) are mostly unknown”, begins the study’s abstract. “Our aim was to assess cannabis use in PD and MS and compare results of self-reported assessments of neurological disability between current cannabis users and non-users.”
For the study; “An anonymous web-based survey was hosted on the Michael J. Fox Foundation and the National Multiple Sclerosis Society webpages from 15 February to 15 October 2016. The survey collected demographic and cannabis use information, and used standardized questionnaires to assess neurological function, fatigue, balance, and physical activity participation. Analysis of variance and chi-square tests were used for the analysis.”
The survey was viewed 801 times, and 595 participants were in the final data set. 76% and 24% of the respondents reported PD and MS respectively. Current users “reported high efficacy of cannabis, 6.4 (SD 1.8) on a scale from 0 to 7 and 59% reported reducing prescription medication since beginning cannabis use.” Current cannabis users “were younger and less likely to be classified as obese”. Cannabis users reported “lower levels of disability, specifically in domains of mood, memory, and fatigue”.
The study concludes by stating that; “Cannabis may have positive impacts on mood, memory, fatigue, and obesity status in people with PD and MS.”
The full study can be found by clicking here.